Procyrion develops technology solutions and offers a catheter-based circulatory support technologies.
Procyrion has raised $47.7M in total funding. The most recent round was Series E. The last funding was announced in February 2024.
Procyrion's investors include Bluebird Ventures, Fannin Innovation Studio, Jefferson River Capital, Scientific Health Development Partners, Houston Angel Network.
Procyrion is headquartered in Houston, United States.
Procyrion develops technology solutions and offers a catheter-based circulatory support technologies.
Procyrion is at the Series E stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Procyrion — Funding & Investors." VCBacked, February 5, 2024, https://www.vcbacked.co/company/procyrion. Accessed July 31, 2026.
VCBacked. (2024). Procyrion — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/procyrion
{{cite web |title=Procyrion — Funding & Investors |url=https://www.vcbacked.co/company/procyrion |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated